These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16075257)

  • 1. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.
    Booth DR; Arthur AT; Teutsch SM; Bye C; Rubio J; Armati PJ; Pollard JD; Heard RN; Stewart GJ;
    J Mol Med (Berl); 2005 Oct; 83(10):822-30. PubMed ID: 16075257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis.
    McKay FC; Swain LI; Schibeci SD; Rubio JP; Kilpatrick TJ; Heard RN; Stewart GJ; Booth DR
    Genes Immun; 2008 Jan; 9(1):1-6. PubMed ID: 17928869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
    Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.
    Simsek H; Geckin H; Sensoz NP; List EO; Arman A
    J Mol Neurosci; 2019 Jan; 67(1):38-47. PubMed ID: 30443838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis.
    McDonnell GV; Mawhinney H; Graham CA; Hawkins SA; Middleton D
    J Neurol Sci; 1999 May; 165(1):77-83. PubMed ID: 10426152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
    Knapp R; Hardtstock F; Krieger J; Wilke T; Maywald U; Chognot C; Muros-Le Rouzic E; Craveiro L
    Mult Scler Relat Disord; 2022 Dec; 68():104245. PubMed ID: 36306609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic association studies of tumour necrosis factor alpha and beta and tumour necrosis factor receptor 1 and 2 polymorphisms across the clinical spectrum of multiple sclerosis.
    McDonnell GV; Kirk CW; Middleton D; Droogan AG; Hawkins SA; Patterson CC; Graham CA
    J Neurol; 1999 Nov; 246(11):1051-8. PubMed ID: 10631637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
    Malhotra S; Fissolo N; Tintoré M; Wing AC; Castilló J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroinflammation; 2015 Mar; 12():48. PubMed ID: 25879961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
    Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
    Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
    Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
    Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Income in Multiple Sclerosis Patients with Different Disease Phenotypes.
    Kavaliunas A; Manouchehrinia A; Danylaite Karrenbauer V; Gyllensten H; Glaser A; Alexanderson K; Hillert J
    PLoS One; 2017; 12(1):e0169460. PubMed ID: 28081163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of transforming growth factor (TGF)-beta 1 and beta 2 gene polymorphisms with multiple sclerosis (MS) in Northern Ireland.
    McDonnell GV; Kirk CW; Hawkins SA; Graham CA
    Mult Scler; 1999 Apr; 5(2):105-9. PubMed ID: 10335519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells.
    Sanders KA; Benton MC; Lea RA; Maltby VE; Agland S; Griffin N; Scott RJ; Tajouri L; Lechner-Scott J
    Clin Epigenetics; 2016; 8(1):87. PubMed ID: 27570566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis.
    Leech S; Kirk J; Plumb J; McQuaid S
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):86-98. PubMed ID: 17239011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-associated differences of perforin polymorphisms in the susceptibility to multiple sclerosis.
    Camiña-Tato M; Morcillo-Suárez C; Bustamante MF; Ortega I; Navarro A; Muntasell A; López-Botet M; Sánchez A; Carmona P; Julià E; Tortola MT; Audí L; Oksenberg JR; Martin R; Montalban X; Comabella M
    J Immunol; 2010 Nov; 185(9):5392-404. PubMed ID: 20921521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of Polish patients with primary progressive multiple sclerosis.
    Brola W; Sobolewski P; Żak M; Flaga S; Fudala M; Siutka D; Kapica K; Chorąży M; Kułakowska A; Perenc A; Bartosik-Psujek H; Psujek M; Głąbiński A; Pawełczyk M; Gacek S; Potemkowski A
    Mult Scler Relat Disord; 2019 Aug; 33():33-38. PubMed ID: 31146082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
    Sombekke MH; van der Voort LF; Kragt JJ; Nielsen JM; Guzel H; Visser A; Oudejans CB; Crusius JB; Peña AS; Vrenken H; Polman CH; Killestein J
    Mult Scler; 2011 Aug; 17(8):922-30. PubMed ID: 21543551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
    Stoevring B; Frederiksen JL; Christiansen M
    Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.